查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球外科成像市场 - 2023-2030年
市场调查报告书
商品编码
1290360

全球外科成像市场 - 2023-2030年

Global Surgical Imaging Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球外科成像市场的规模在2022年达到20.473亿美元，预计到2030年将见证有利可图的增长，达到33305亿美元。在预测期内（2023-2030），全球外科成像市场预计将呈现6.4%的复合年增长率。

手术成像在肿瘤手术中至关重要，包括肿瘤切除术、活检程序和淋巴结切除术。肿瘤外科医生通过使用包括CT、MRI和PET-CT扫描在内的成像方式，帮助肿瘤定位、分期和确定手术切除的精确边缘，能够优化手术方法，保证肿瘤的完全切除。

市场动态

慢性疾病的负担日益加重，在预测期内推动了全球外科成像市场的增长。

在工业化国家和发展中国家，慢性非传染性疾病（NCDs）构成死亡和残疾的主要原因。全球每10人中就有7人死于四种主要的非传染性疾病：癌症、心血管疾病、慢性呼吸系统疾病和糖尿病。80%与非传染性疾病相关的死亡发生在低收入和中等收入国家。

根据世界卫生组织（WHO）2022年的估计，非传染性疾病（NCDs）每年造成4100万人死亡，占全世界所有死亡人数的74%。全世界每年有1700万人在70岁之前死于非传染性疾病；这些过早的死亡有86%发生在低收入和中等收入国家。

技术进步为外科成像市场提供了潜在的增长机会

为了在未来的外科手术中成功互补，人类和医疗技术将需要越来越多的合作。例如，2022年1月，由健康技术组织皇家飞利浦公司开发的图像引导治疗移动C臂系统 - Zenition，现在将为医生提供先进的新的三维图像引导能力，提高临床准确性和效率，旨在提高接受血管内治疗的病人的效果。

COVID-19影响分析

COVID-19大流行病对外科成像市场产生了重大影响。由于该大流行病对外科专业的实质性和广泛的影响，全球范围内的选择性手术都被推迟了。

根据2022年发表在Jornal of Minimal Access Surgery上的文章，与传统的开放性手术相比，微创手术（MIS）采用较小的切口，对组织的损伤较小，失血量最小，缩短了病人必须住院的时间，并产生了良好的短期和可比的长期效果。为了对抗这种大流行病，外科医生可以在MIS领域获得成功。

俄罗斯-乌克兰冲突分析

俄乌战争对外科影像市场的影响是复杂和多方面的。在冲突期间，医疗资源和优先事项可能转向紧急和创伤护理，对非紧急程序和外科成像系统等专业设备的关注和投资较少。由于医疗系统优先考虑即时和关键的需求，而不是投资于先进的成像技术，因此对外科成像的需求受到影响。

目录

第一章：方法和范围

  • 研究方法
  • 报告的研究目标和范围

第二章：定义和概述

第三章：执行摘要

  • 按产品分类的摘要
  • 按技术分类
  • 按模式分析
  • 按应用分类
  • 按终端用户分类
  • 按地区分类

第4章：动态变化

  • 影响因素
    • 驱动因素
      • 慢性疾病发病率的增加推动了全球外科成像市场的增长。
    • 限制因素
      • 设备成本高，阻碍了全球外科成像市场的增长。
    • 机会
      • 技术进步
    • 影响分析

第五章：行业分析

  • 波特五力分析
  • 供应链分析
  • 未满足的需求
  • 监管分析

第六章：COVID-19分析

  • 对COVID-19的分析
    • COVID-19之前的情况
    • COVID-19期间的情况
    • COVID-19之后的情况
  • 在COVID-19期间的定价动态
  • 需求-供应谱系
  • 大流行期间与市场有关的政府倡议
  • 制造商的战略倡议
  • 结语

第7章 ：俄罗斯-乌克兰战争分析

第八章：人工智能分析

第九章：按产品分类

  • C-武器
  • O型军械
  • G-Arms
  • 影像配件
  • 其他产品

第十章：按技术分类

  • 平板检测器
  • 图像增强器
  • 其他技术

第11章：按模式分类

  • X-射线
  • 核磁共振成像
  • CT扫描
  • 超声波
  • 其他

第十二章：按应用分类

  • 神经系统成像
  • 骨科和创伤成像
  • 心血管成像
  • 胃肠道成像
  • 普通外科成像
  • 泌尿系统成像
  • 其他

第13章 ：按终端用户分类

  • 医院
  • 非住院外科诊所
  • 专科诊所
  • 其他

第十四章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第15章 ：竞争格局

  • 竞争格局
  • 产品标杆
  • 公司份额分析
  • 主要发展和战略

第16章 ：公司简介

  • GE Healthcare
    • 公司概述
    • 产品组合和描述
    • 财务概况
    • 主要发展情况
  • Medtronic Plc.
  • Siemens Healthineers AG
  • Thales Group
  • Shimadzu Corporation
  • Hitachi Ltd
  • Koninklijke Philips N.V.
  • Ziehm Imaging GmbH
  • OrthoScan Inc.
  • Genoray Co. Ltd.

第十七章 ：附录

简介目录
Product Code: MD1541

Market Overview

The Global Surgical Imaging Market size reached US$ 2,047.3 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 3,330.5 billion by 2030. The global surgical imaging market is expected to exhibit a CAGR of 6.4% during the forecast period (2023-2030).

Surgical imaging is crucial in oncological surgeries, including tumor resections, biopsy procedures, and lymph node dissections. Oncologic surgeons are able to optimize the surgical approach and guarantee total tumor excision by using imaging modalities including CT, MRI, and PET-CT scans that aid in tumor localization, staging, and determining precise margins for surgical removal.

Market Dynamics

The Growing Burden Of Chronic Diseases Is Boosting The Global Surgical Imaging Market Growth During The Forecast Period.

In both industrialized and developing countries, chronic non-communicable diseases (NCDs) constitute the main cause of death and disability. Seven out of ten fatalities globally are caused by the four primary NCDs: cancer, cardiovascular disease, chronic respiratory illnesses, and diabetes. Eighty percent of NCD-related deaths take place in low- and middle-income nations.

According to a World Health Organisation (WHO) estimate from 2022, noncommunicable diseases (NCDs) account for 41 million annual deaths or 74% of all fatalities worldwide. 17 million people worldwide pass away from an NCD before they turn 70 each year; 86% of these untimely deaths take place in low- and middle-income nations.

Technological Advancements Are Providing The Surgical Imaging Market With Prospective Growth Opportunities

In order to successfully complement each other's work in the future of surgery, humans and healthcare technology will need to work together more and more. For instance, in January 2022, The Image-Guided Therapy Mobile C-arm System - Zenition, developed by Royal Philips, a health technology organization, will now provide physicians with advanced new 3D image guidance capabilities, enhancing clinical accuracy and efficiency and aim to improve the results for patients receiving endovascular treatment.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the surgical imaging market. Elective surgeries have been postponed globally as a result of the pandemic's substantial and wide-ranging impact on surgical specialties.

As per the article published in Jornal of Minimal Access Surgery in 2022, when compared to traditional open surgery, minimally invasive surgery (MIS) employs a smaller incision, causes less damage to tissues, minimizes blood loss, shortens the time patients must stay in the hospital and produces superior short-term and comparable long-term results. In order to combat this pandemic, surgeons could achieve success in the field of MIS.

Russia-Ukraine Conflict Analysis

The impact of the Russia-Ukraine war on the surgical imaging market is complex and multifaceted. During times of conflict, healthcare resources and priorities may shift towards emergency and trauma care, leaving less focus and investment in non-emergency procedures and specialized equipment like surgical imaging systems. The demand for surgical imaging is impacted as healthcare systems prioritize immediate and critical needs over investments in advanced imaging technologies.

Segment Analysis

The global surgical imaging market is segmented based on product, material, distribution channel, end-user, and region.

The Gastrointestinal Imaging Segment Is Expected To Hold A Dominant Position In The Market Over The Forecast Period.

The gastrointestinal imaging segment accounted for the highest market stake accounting for approximately 25.3% of the surgical imaging market in 2022. Surgical imaging plays a significant role in gastrointestinal procedures such as laparoscopic or robotic-assisted surgeries for conditions like colorectal cancer, gallbladder diseases, and bariatric surgery.

Furthermore, in September 2022, the newest surgical visualization platform from Olympus Corporation, a manufacturer of optics and reprography products, VISERA ELITE III, was introduced to meet the needs of healthcare professionals (HCPs) performing endoscopic procedures in a variety of medical specialties. Numerous imaging capabilities provided by VISERA ELITE III, supported by a single system, enable minimally invasive procedures such as laparoscopic colectomy and laparoscopic cholecystectomies.

Geographical Analysis

Increasing Collaborations And Partnerships Among The Key Players, Increasing Chronic Diseases, And Advancement In Surgical Imaging Dominate the North American Region.

North America is expected to dominate the surgical imaging market, accounting for around one-third of this market. The surgical imaging market is driven by factors such as collaborations among key players, and advanced healthcare facilities in the North American region.

For instance, in November 2022, Hospital for Special Surgery (HSS), the top academic medical center in the world for musculoskeletal health, and medical device and technology company Lazurite collaborated based on Lazurite's ArthroFree Wireless Surgical Camera System, the first wireless surgical camera system to be cleared for market by the U.S. Food and Drug Administration for arthroscopy and general endoscopy.

Competitive Landscape

The major global players in the market include: GE Healthcare, Medtronic Plc., Siemens Healthineers AG, Thales Group, Shimadzu Corporation, Hitachi Ltd, Koninklijke Philips N.V., Ziehm Imaging GmbH, OrthoScan Inc., and Genoray Co. Ltd. among others.

Why Purchase the Report?

  • To visualize the global surgical imaging market segmentation based on the product, technology, application, modality, end-users, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the surgical imaging market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global surgical imaging market report would provide approximately 77 tables, 82 figures, and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Technology
  • 3.3. Snippet by Modality
  • 3.4. Snippet by Application
  • 3.5. Snippet by End-users
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in the prevalence of chronic diseases is driving the global surgical imaging market growth.
    • 4.1.2. Restraints
      • 4.1.2.1. High equipment cost is hampering the growth of the global surgical imaging market.
    • 4.1.3. Opportunity
      • 4.1.3.1. Technological advancements
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Analysis

9. By Product

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.1.2. Market Attractiveness Index, By Product
  • 9.2. C-Arms*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. O-Arms
  • 9.4. G-Arms
  • 9.5. Imaging Accessories
  • 9.6. Others

10. By Technology

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.1.2. Market Attractiveness Index, By Technology
  • 10.2. Flat Panel Detectors*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Image Intensifier
  • 10.4. Others

11. By Modality

    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.1.2. Market Attractiveness Index, By Modality
  • 11.2. X-Ray*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. MRI
  • 11.4. CT Scanning
  • 11.5. Ultrasound
  • 11.6. Others

12. By Application

    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.1.2. Market Attractiveness Index, By Application
  • 12.2. Neurological Imaging*
    • 12.2.1. Introduction
    • 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3. Orthopaedic and Trauma Imaging
  • 12.4. Cardiovascular Imaging
  • 12.5. Gastrointestinal Imaging
  • 12.6. General Surgery Imaging
  • 12.7. Urological Imaging
  • 12.8. Others

13. By End-users

  • 13.1. Introduction
    • 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 13.1.2. Market Attractiveness Index, By End-users
  • 13.2. Hospitals*
    • 13.2.1. Introduction
    • 13.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 13.3. Ambulatory Surgical Clinics
  • 13.4. Specialty Clinics
  • 13.5. Others

14. By Region

  • 14.1. Introduction
    • 14.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 14.1.2. Market Attractiveness Index, By Region
  • 14.2. North America
    • 14.2.1. Introduction
    • 14.2.2. Key Region-Specific Dynamics
    • 14.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 14.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 14.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 14.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 14.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.2.8.1. The U.S.
      • 14.2.8.2. Canada
      • 14.2.8.3. Mexico
  • 14.3. Europe
    • 14.3.1. Introduction
    • 14.3.2. Key Region-Specific Dynamics
    • 14.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 14.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 14.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 14.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 14.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.3.8.1. Germany
      • 14.3.8.2. The U.K.
      • 14.3.8.3. France
      • 14.3.8.4. Italy
      • 14.3.8.5. Spain
      • 14.3.8.6. Rest of Europe
  • 14.4. South America
    • 14.4.1. Introduction
    • 14.4.2. Key Region-Specific Dynamics
    • 14.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 14.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 14.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 14.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 14.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.4.8.1. Brazil
      • 14.4.8.2. Argentina
      • 14.4.8.3. Rest of South America
  • 14.5. Asia-Pacific
    • 14.5.1. Introduction
    • 14.5.2. Key Region-Specific Dynamics
    • 14.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 14.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 14.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 14.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users
    • 14.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 14.5.8.1. China
      • 14.5.8.2. India
      • 14.5.8.3. Japan
      • 14.5.8.4. Australia
      • 14.5.8.5. Rest of Asia-Pacific
  • 14.6. Middle East and Africa
    • 14.6.1. Introduction
    • 14.6.2. Key Region-Specific Dynamics
    • 14.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 14.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 14.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 14.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 14.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-users

15. Competitive Landscape

  • 15.1. Competitive Scenario
  • 15.2. Product Benchmarking
  • 15.3. Company Share Analysis
  • 15.4. Key Developments and Strategies

16. Company Profiles

  • 16.1. GE Healthcare*
    • 16.1.1. Company Overview
    • 16.1.2. Product Portfolio and Description
    • 16.1.3. Financial Overview
    • 16.1.4. Key Developments
  • 16.2. Medtronic Plc.
  • 16.3. Siemens Healthineers AG
  • 16.4. Thales Group
  • 16.5. Shimadzu Corporation
  • 16.6. Hitachi Ltd
  • 16.7. Koninklijke Philips N.V.
  • 16.8. Ziehm Imaging GmbH
  • 16.9. OrthoScan Inc.
  • 16.10. Genoray Co. Ltd.

LIST NOT EXHAUSTIVE

17. Appendix

  • 17.1. About Us and Services
  • 17.2. Contact Us